Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of GLP1-RAs on Inflammation and Endothelial biomarkerS in Type 2 diABetes meLlitus patiEnts: STABLE-GLP1 Trial

NCT07314684 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07314684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07314684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of GLP1-RAs on Inflammation and Endothelial biomarkerS in Type 2 diABetes meLlitus patiEnts: STABLE-GLP1 Trial
Lead sponsor
Federico II University
Phase
Phase 4
Overall status
Recruiting
Start date
September 8, 2025
Completion date
March 8, 2027
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

t2dm (type 2 diabetes mellitus)